Evidence map›Paper›PMID 32732956›Full record

ArticleScientific reports2020

Lipoxins, RevD1 and 9, 13 HODE as the most important derivatives after an early incident of ischemic stroke.

Małgorzata Szczuko, Dariusz Kotlęga, Joanna Palma, Agnieszka Zembroń-Łacny, Anna Tylutka, Monika Gołąb-Janowska, Arleta Drozd

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Małgorzata SzczukoDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, Broniewskiego 24 street, 71-460, Szczecin, Poland. malgorzata.szczuko@pum.edu.pl.ORCID http://orcid.org/0000-0001-9808-0624
Dariusz KotlęgaDepartment of Neurology, Pomeranian Medical University, Szczecin, Poland.
Joanna PalmaDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, Broniewskiego 24 street, 71-460, Szczecin, Poland.
Agnieszka Zembroń-ŁacnyDepartment of Applied and Clinical Physiology, University of Zielona Góra, Zielona Gora, Poland.
Anna TylutkaDepartment of Applied and Clinical Physiology, University of Zielona Góra, Zielona Gora, Poland.
Monika Gołąb-JanowskaDepartment of Neurology, Pomeranian Medical University, Szczecin, Poland.
Arleta DrozdDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, Broniewskiego 24 street, 71-460, Szczecin, Poland.
Pomeranian Medical University · PLUniversity of Zielona Góra · PLState Higher Vocational School in Głogów · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is limited information available regarding the association of plasma free fatty acids (FFA) and inflammation mediators with ischemic stroke. At the same time, new treatment strategies are being pursued. The aim of this study was to carry out a thorough analysis of inflammation with multiple FFA-derivative mediators after and ischemic stroke and standard treatment. HPLC separations of 17 eicosanoids were performed using an Agilent Technologies 1,260 liquid chromatograph. The profiles of the esters of fatty acids were labelled by means of gas chromatography. FFA, and eicosanoid profiles in the group of patients after ischemic stroke significantly differed from the profile of the control group. Studies confirmed the involvement of derivative synthesis pathways responsible for the inflammation, especially palmitic acid (9 and 13 HODE), arachidonic acid, EPA and DHA. Arachidonic acid derivatives were synthesised on 5LOX, 15 LOX and COX pathways with the participation of prostaglandins while omega 3 derivatives strengthened the synthesis of resolvins, RevD1 in particular. The ability to accelerate the quenching of inflammation after ischemic stroke seems to be a promising strategy of stroke treatment in its early stage. In this context, our study points to lipoxins, RevD1, and 9, 13 HODE as the most important derivatives.

Indexed as

Arachidonic AcidsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3HumansInflammationIschemic StrokeLipoxinsPalmitic AcidsProstaglandinsSignal TransductionArachidonic AcidsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3LipoxinsPalmitic AcidsProstaglandinsresolvin D1

Identifiers

PMID32732956
PMCPMC7393087
OpenAlexW3046035090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.